Top U.S. trade negotiator discusses COVID-19 vaccine ramp-up with Novavax
The Hindu
Novavax’s COVID-19 vaccine is not currently authorised for use in the United States.
U.S. Trade Representative Katherine Tai discussed increasing COVID-19 vaccine production in a virtual meeting on April 27 with an executive of drugmaker Novavax, Ms. Tai’s office said in a statement. Ms. Tai and Novavax Executive Vice President John Trizzino also discussed a proposal before the World Trade Organisation to waive certain intellectual property rights in response to the coronavirus pandemic, the USTR statement said. “Ambassador Tai sought Mr. Trizzino’s views on steps Novavax is taking to quickly increase equitable production and distribution of vaccines in the United States and around the world,” the statement said.More Related News